在急性髓性白血病的分化疗法最近的发展
Ugo Testa1, Germana Castelli1, Elvira Pelosi1
1Department of Oncology, Istituto Superiore di Sanità, 00161 Rome, Italy.
Cancers
|April 14, 2025
概括
差异化疗法在急性骨髓性白血病 (AML) 和急性前兆细胞性白血病 (APL) 之外的急性骨髓性白血病 (AML) 中表现有前途. 针对特定突变的新型药物正在诱导白血病细胞分化,并在AML治疗中显示治疗效果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 急性骨髓性白血病 (AML) 涉及骨髓原生细胞分化停止.
- 差异化疗法在急性前列细胞白血病 (APL) 中有效,使用的是视网酸和三氧化物.
- 标准的AML治疗依赖于密集化疗,在非APL亚型中成功程度有限.
研究的目的:
- 探索非APLAML亚型的分化疗法的潜力.
- 识别和评估AML的新型治疗点和药物.
- 评估特定药理学药剂在诱导白血病细胞分化的有效性.
主要方法:
- 对确定AML治疗点的分子研究的审查.
- 对新型药理学药物的分析,包括突变异酸脱酶 (IDH1和IDH2) 的抑制剂,氨酸特异性去甲基酶-1 (LSD1) 和Menin.
- 评估这些药物诱导白血病细胞分化的能力.
主要成果:
- 针对AML的向疗法已经出现,基于分子分析.
- 特定的药物,如IDH1/IDH2,LSD1和Menin抑制剂显示出潜在的作用.
- 这些药物已经显示出诱导白血病细胞分化的能力.
结论:
- 差异化疗法是超越APL的AML的一个有希望的策略.
- 向性药物为AML治疗提供了一类新的药理选择.
- 用新药诱导白血病细胞分化显示出显著的治疗疗效.
更多相关视频
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
29.1K
06:28Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
Published on: November 10, 2023
1.7K
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
3.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.1K
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
Forced Transdifferentiation
1.8K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
Artificial...
1.8K
Bone Marrow Sampling and Transplants
263
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
263
